Obesity has deleterious effects on cognitive function in the elderly adults. In mice, aging exacerbates obesity-induced oxidative stress, microvascular dysfunction, blood-brain barrier (BBB) disruption, and neuroinflammation, which compromise cognitive health. However, the specific mechanisms through which aging and obesity interact to remain elusive. Previously, we have shown that Nrf2 signaling plays a critical role in microvascular resilience to obesity and that aging is associated with progressive Nrf2 dysfunction, promoting microvascular impairment. To test the hypothesis that Nrf2 deficiency exacerbates cerebromicrovascular dysfunction induced by obesity Nrf2 +/+ and Nrf2 -/-, mice were fed an adipogenic high-fat diet (HFD). Nrf2 deficiency significantly exacerbated HFD-induced oxidative stress and cellular senescence, impairment of neurovascular coupling responses, BBB disruption, and microglia activation, mimicking the aging phenotype. Obesity in Nrf2 -/-mice elicited complex alterations in the amyloidogenic gene expression profile, including upregulation of amyloid precursor protein. Nrf2 deficiency and obesity additively reduced long-term potentiation in the CA1 area of the hippocampus. Collectively, Nrf2 dysfunction exacerbates the deleterious effects of obesity, compromising cerebromicrovascular and brain health by impairing neurovascular coupling mechanisms, BBB
Currently, close to 70% of Americans aged 65 years and over are overweight and over 35% are obese and it is predicted that nearly half of the elderly population in the United States will be obese by 2030. Epidemiological and clinical studies, including the Framingham Offspring Study, demonstrate that a negative correlation exists between adiposity and cognitive function and that the deleterious effects of obesity on higher cortical function are exacerbated in the elderly adults (1) (2) (3) (4) . Common mechanisms that contribute to the effects of aging and obesity are hypothesized to increase susceptibility to both vascular cognitive impairment (VCI) and neurodegeneration, including Alzheimer's disease.
There is an increasing appreciation that alterations at the level of the cerebral microcirculation play a key role in the pathogenesis of both VCI and Alzheimer's disease (AD) in elderly patients (5, 6) . Preclinical studies provide direct mechanistic evidence that advanced age and obesity have multifaceted synergistic effects compromising cerebromicrovascular health (7) (8) (9) (10) , which are causally linked to cognitive decline.
Normal functioning of the central nervous system requires a continuous, tightly-controlled supply of oxygen and nutrients as well as washout of harmful metabolites through uninterrupted cerebral blood flow (CBF) (5) . During periods of intense neuronal activity, there is a requirement for rapid adaptive increases in CBF, which is ensured by a mechanism known as neurovascular coupling. Impairment of neurovascular coupling responses has been causally linked to cognitive decline (11) . Previous studies demonstrate that obesity results in neurovascular uncoupling, which is markedly exacerbated at old age (8) . Although the available clinical and preclinical data suggest that advanced age and obesity have synergistic vascular effects (7) (8) (9) , there are no studies addressing the specific age-related mechanisms through which aging exacerbates obesity-induced neurovascular uncoupling.
There is also increasing evidence to support an essential role for factors that compromise the integrity of the blood-brain barrier (BBB) in the onset and progression of both VCI and Alzheimer's disease (12) , by triggering neuroinflammation, synaptic dysfunction, and neurodegeneration. Experimental and clinical studies suggest that obesity promotes BBB breakdown and activates inflammatory processes, which contribute to obesity-related impairment of cognitive function (13, 14) . Importantly, aging was shown to exacerbate obesity-induced BBB disruption and neuroinflammation (7) , yet, the underlying mechanisms remain obscure.
NF-E2-related factor 2 (Nrf2) is an evolutionarily highly conserved pro-survival transcription factor that upregulates the expression of numerous genes involved in cellular resilience including enzymes that detoxify reactive oxygen species (ROS), as well as those with other antioxidant properties (15) (16) (17) (18) (19) . In young organisms, Nrf2-driven pathways attenuate vascular oxidative stress and limit the damage caused by the increased production of ROS induced by obesity (18, 19) . Previously, we have demonstrated that aging is associated with Nrf2 dysfunction in the vasculature, which was proposed to increase sensitivity of aged organisms to oxidative stressinduced vascular damage (20, 21) . Further, indirect evidence raises the possibility that impaired Nrf2 signaling and increased cerebral oxidative stress may contribute to obesity-induced declines in cognitive performance in the aged brain (22) .
The present study was designed to directly test the hypothesis that Nrf2 deficiency exacerbates obesity-induced neurovascular dysfunction, BBB disruption, neuroinflammation, and synaptic dysfunction in the hippocampus, mimicking the aging phenotype. To test our hypothesis, we assessed changes in whisker stimulation-induced functional hyperaemia in the somatosensory cortex, BBB function, microglia activation, hippocampal cytokine expression, and markers of oxidative stress in high-fat diet-fed obese Nrf2 deficient (Nrf2 -/-) and wild type mice. To determine whether enhanced neuroinflammation triggers early processes involved in the development of VCI and/ or AD, we also studied long-term potentiation (LTP) and hippocampal expression of genes involved in regulation of the cellular amyloid precursor protein (APP)-dependent signaling pathways, β-amyloid generation and the pathogenesis of tauopathy.
Methods

Experimental Animals, High-fat Diet Feeding
Male WT mice (Nrf2 +/+ ) and Nrf2 KO mice on an Institute of Cancer Research (ICR) background (Nrf2 -/-) were used as reported previously (16) (17) (18) . In this study, only male mice were studied to exclude the possible confounding effects of the estrous cycle in females. The mice were housed in an environmentally-controlled vivarium with unlimited access to water and a controlled photoperiod (12-hour light; 12-hour dark). Body weight was recorded biweekly. All mice were maintained according to National Institutes of Health guidelines and all animal use protocols were approved by the Institutional Animal Care and Use Committees of the participating institutions. At 3 months of age, both wild-type control and Nrf2 -/-mice were assigned to two groups and were fed a standard D12492 diet (SD; 10% kcal from fat) or D12450B diet modified to provide 60% of calories from fat (high-fat diet; HFD; Research Diets Inc., New Brunswick, NJ), as described previously (23) . The animals continued on the specific diets (with water and food ad libitum) for 5 months. There was considerable variation in the initial body weight (41 ± 2 g and 36 ± 2 g for Nrf2 +/+ and Nrf2 -/-mice, respectively) and HFD-induced weight gain in the mice and the intent of the studies was to determine the influence of HFD and Nrf2 on cerebromicrovascular health, independent of body weight gain differences. Therefore, we selected a cohort of mice from the larger population with a similar HFD-induced gain in mean body weight (≥20%), which indicates that results in Figures 1-4 are independent of body weight gain differences. An inherited retinal defect leading to rapid degeneration of photoreceptor cells is known to develop in ICR mice that are homozygous for a recessive mutation in the Pdeb rd1 gene (24) . As impaired vision confounds the effects of behavioral studies, we screened the animals for the presence of this mutation in their genome and excluded homozygous carriers (n = 3) from the behavioral studies.
Serum Biomarkers
Whole blood was collected at sacrifice and was centrifuged at 2,500 x g for 20 minutes at 4°C; serum was collected, aliquoted, and stored at −80°C. Blood glucose was determined using an Ascensia Elite glucose meter (Bayer, Mishawaka, IN). The serum biochemical profile was assessed by Vance Veterinary Laboratories (Oklahoma City, OK). Circulating levels of cytokines, chemokines, and other inflammatory markers relevant for aging research (7) (8) (9) 23, 25) were analyzed using a magnetic bead-based multiplex protein array system (EMD Millipore) according to the manufacturer's protocol.
Novel Object Recognition test
After 5 months on the HFD, the novel object recognition task was performed to characterize the effect of obesity on learning and memory (11, 26) . The results of the test are influenced by both hippocampal and cortical impairment. The test consists of a habituation phase, acquisition (familiarization) phase, and trial phase. During the habituation phase, the animals explored the empty open-field arena for 5 minutes. Then, in the acquisition phase, the mice explore two identical objects for 2 minutes. After a 4-hour delay, a trial phase occurred. During this period, animals explored the familiar object and a novel object for 2 minutes. Exploration of the objects was defined as directing the nose at a distance ≤2 cm to the object and/or touching it with the nose. For data collection and analysis, Ethovision software (Noldus Information Technology Inc., Leesburg, VA) was used. Sitting or climbing on it was not considered as an exploration. All objects used in this study were made of washable odorless plastic and were different in shapes and colors but identical in size. A percent of time spent exploring the novel object relative to the total time spent exploring both objects was used as a measure of novel object recognition. The Recognition Index (representing the time spent investigating the novel object [T novel ] relative to the total object investigation) was used as the main index of retention, which was calculated according to the following formula: (Recognition Index = T novel /[T novel + T familiar ]). The arena and the objects were cleaned with 70% ethanol between the trials to prevent the existence of olfactory cues.
Determination of Hippocampal Protein Carbonyl Content
As biomarkers of oxidative stress, protein carbonyl groups were quantified in cortical samples using the Protein Carbonyl Colorimetric Assay (Cayman Chemicals), following the manufacturer's protocol.
Measurement of Neurovascular Coupling Responses
After behavioral testing, neurovascular coupling responses in the whisker barrel cortex elicited by contralateral whisker stimulation were assessed in anesthetized mice, as previously described (8, 11, (27) (28) (29) (30) . In brief, mice in each group were anesthetized (α-chloralose (50 mg/kg, i.p.)/urethane (750 mg/kg, i.p.), endotracheally intubated and ventilated (MousVent G500; Kent Scientific Co, Torrington, CT). A thermostatic heating pad (Kent Scientific Co, Torrington, CT) was used to maintain rectal temperature at 37°C. End-tidal CO 2 (including dead space) was controlled between 3.2% and 3.7% to keep blood gas values within the physiologic range. Arterial blood pressure was monitored throughout the experiment with a noninvasive blood pressure monitor (CODA Monitor; Kent Scientific Co). The blood pressure was within the physiologic range throughout the experiments (90-110 mm Hg). Mice were immobilized, placed on a stereotaxic frame (Leica Microsystems Inc, Buffalo Grove, IL), the scalp and periosteum were pulled aside. The animals were equipped with an open cranial window as described (29) and a glass-insulated tungsten microelectrode (impedance, 2-3 MΩ, Kation Scientific, LLC, Minneapolis, MN) was inserted stereotaxically into the left barrel cortex (3 mm lateral and 1.5 mm caudal to bregma; depth of 0.6 mm) through the ACSF-perfused open cranial window for recording local field potentials. An Ag/AgCl electrode inserted in the neck muscles served as reference electrode. Changes in cerebral blood flow (CBF) were assessed above the left barrel cortex using a laser Doppler probe (Transonic Systems Inc., Ithaca, NY) as described (29) . The right whisker pad was stimulated by a bipolar stimulating electrode placed to the ramus infraorbitalis of the trigeminal nerve and into the masticatory muscles. The stimulation protocol used to investigate NVC and somatosensory evoked field potentials consisted of 3 stimulation trials with an intertrial interval of 60 seconds, each delivering a 30-second train of electrical pulses (5 Hz, 1 mA, intensity, and 0.3 ms pulse width) to the mystacial pad. Changes in CBF were averaged and expressed as percent (%) increase from the baseline value. The electrical signal was amplified with a AC/DC differential amplifier (high pass at 1Hz, low pass at 1kHz) (Model 3000, A-M Systems, Inc. Carlsborg, WA), and digitalized by the PowerLab/Labchart data acquisition system (AD Instruments, Colorado Springs, CO) with the sampling rate of 40 kHz. The negative amplitude in the somatosensory evoked field potential response was considered as the field excitatory postsynaptic potential (fEPSP) (31) . Experiments lasted ~30-40 minutes/mouse, which permitted stable physiological parameters to be obtained. The experimenter was blinded to the treatment of the animals. / cyclin-dependent kinase inhibitor 2A/ Cdkn2a) and genes known to be involved in β-amyloid generation and Alzheimer's disease using validated TaqMan probes (Applied Biosystems) and a Strategen MX3000 platform, as previously reported (7, 8, 26) . In brief, total RNA was isolated from cortical and hippocampal samples from each experimental group with a Mini RNA Isolation Kit (Zymo Research, Orange, CA) and was reverse transcribed using Superscript III RT (Invitrogen) (32, 33) . Quantification was performed using the efficiency-corrected ΔΔCq method. The relative quantities of the reference genes Hprt1, Gapdh, Actb and 18S were determined and a normalization factor was calculated based on the geometric mean for internal normalization. Fidelity of the PCR reaction was determined by melting temperature analysis and visualization of the product on a 2% agarose gel.
Quantitative Real-Time RT-PCR
Quantitative Mass Spectrometry Analysis
Selective reaction monitoring mass spectrometry was used to quantify Nrf2-dependent antioxidant protein expression in cortical samples as previously described (34) . For these assays, 60-μg amounts of tissue lysates were mixed with 8 pmol of bovine serum albumin (BSA) as an internal standard and 50 μL of 10% SDS. The samples were heated at 80°C for 15 minutes before precipitating the proteins in 80% acetone overnight at −20°C. The protein pellet was dissolved in 60 μL of sample buffer and a 20-μL aliquot containing 20 μg of protein run 1.5 cm into a 12.5% SDS-polyacrylamide gel. The gel was fixed and stained with GelCode Blue (Pierce). For each sample, the entire 1.5-cm lane was cut out of the gel and divided coarsely. The gel pieces were washed to remove the stain, reduced with DTT, alkylated with iodoacetamide, and digested with 1 μg of trypsin overnight at room temperature. The peptides produced in the digest were extracted with 50% methanol, 10% formic acid in water. The extract was evaporated to dryness and reconstituted in 150 μL of 1% acetic acid in water for analysis. The samples were analyzed using selective reaction monitoring with a triple quadrupole mass spectrometer (ThermoScientific TSQ Vantage) configured with a splitless capillary column HPLC system (Eksigent, Dublin, CA). Samples (10 μL) were injected onto a 10 cm × 75 μm C18 capillary column (Phenomenex, Jupiter C18). The column was eluted at 160 nL/min with a 30-minute linear gradient of acetonitrile in 0.1% formic acid. Data were processed by using Pinpoint to find and integrate the correct peptide chromatographic peaks. The response for each protein was taken as the total response for all peptides monitored. To quantify protein expression, the relative abundance of each protein was first normalized to the BSA internal standard and then normalized to the geometric mean of cellular reference proteins (34) .
Western Blotting
To assess BBB integrity immunoblotting studies for extravasated IgG in hippocampal homogenates were performed. In brief, hippocampal samples (n = 4-6 per experimental group) from mice transcardially perfused with ice-cold PBS were homogenized in icecold phosphate buffered saline (PBS) with 1:100 Protease Inhibitor Cocktail (Sigma Aldrich). Samples were then subjected to SDS-PAGE gel electrophoresis and transferred to a nitrocellulose membrane. Membranes were blocked with 5% BSA (in 2% Tween in PBS, for 2 hours, at room temperature) and incubated with a primary antibody directed against IgG (sheep anti-mouse IgG, peroxidase-linked whole antibody, 1:500, at room temperature, Amersham NXA931) and then incubated with a appropriate HRP-conjugated secondary antibody (for 2 hours, at room temperature). Membranes were developed using Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare). The relative abundance of studied proteins was determined with densitometry. β-actin (mouse monoclonal, 1:15,000, for 45 minutes, at room temperature, Abcam) was used for normalization purposes.
Immunofluorescent Labeling and Confocal Microscopy
Mice were transcardially perfused with 1× heparin containing PBS, then brains were removed and hemisected. The left hemispheres were fixed overnight in 4% paraformaldehyde, then were cryoprotected in a series of graded sucrose solutions (10%, 20%, and 30% overnight) and frozen in Cryo-Gel (Electron Microscopy Sciences, Hatfield, PA). Coronal sections of 35 µm were cut through the hippocampus and stored free-floating in cryopreservative solution (25% glycerol, 25% ethylene glycol, 25% 0.2M phosphate buffer, 25% distilled water) at −20°C. Selected sections were ~1.6 mm caudal to Bregma, representing the more rostral hippocampus. After washing (3 × 5 minutes with TBS then 3 × 5 minutes with 1× TBS+0.25% TritonX-100), sections were treated with 1% of sodium-borohydride solution for 5 minutes. After a second washing step (3 × 5 minutes with distilled water plus 3 × 5 minutes with 1× TBS) and blocking in 5% BSA/ TBS (with 0.5% Triton X-100, 0.3 M glycin and 1% fish gelatin; for 3 hours), sections were immunostained using primary antibodies overnifght at 4°C. The following primary antibodies were used: goat anti-mouse IgG (1:100, FITC conjugated; Cat N: 005-090-003, Jackson Immuno Research, West Grove, PA) to label extravasated IgG, rabbit anti-mouse Iba1 (1:50, unconjugated; Cat N: 019-19741, Wako, Richmond, VA) to label microglia and rabbit anti-mouse CD68 (1:100, unconjugated; Cat N: ab125212, Abcam, Cambridge, MA) to label activated microglia. The following secondary antibodies were used: Alexa Fluor 647-and Alexa Fluor 568-labeled goat anti-rabbit IgG, (1:1,000, Cat N: 4414, Cell Signaling, Danvers, MA) and goat anti-rat IgG, (1:1,000, Cat N: A11077, Molecular Probes, Grand Island, NY). Sections were washed for 3 × 5 minutes with TBS then 3 × 5 minutes with 1× TBS+0.25% TritonX-100. For nuclear counterstaining, Hoechst 33342 (Life Technologies, Grand Island, NY) was used. Then the sections were transferred to slides and cover-slipped. Confocal images were captured using a Leica SP2 MP confocal laser scanning microscope. Immunofluorescent labeling for Iba1 and CD68 was used to identify microglia and activated microglia, respectively. The relative numbers of Iba1-positive microglia and CD68-positive activated microglia per region of interest in the hippocampus were calculated. In each animal, four randomly selected fields from the hippocampus were analyzed in 6 nonadjacent sections. Six animals per group were analyzed.
Electrophysiological Studies for Synaptic Function and LTP
To assess how Nrf2 deficiency and obesity affect synaptic function, extracellular recordings were performed from acute hippocampal slices with an adapted protocol (11, 35, 36) . Briefly, horizontal hippocampal slices of 325 µm thickness from mice in each cohort were prepared in ice cold solution containing (in mmol/L) sucrose 110, NaCl 60, KCl 3, NaH 2 PO 4 1.25, NaHCO 3 28, sodium ascorbate acid 0.6, glucose 5, MgCl 2 7, CaCl 2 0.5 using a HM650V vibrating microtome (Thermo Scientific). Slices were then transferred to a holding chamber (Scientific Designs, Inc.) which contained oxygenated artificial cerebrospinal fluid (aCSF) of the following composition (in mmol/L) NaCl 126, KCl 2.5, NaH 2 PO 4 1.25, MgCl 2 2, CaCl 2 2, NaHCO 3 26, glucose 10, pyruvic acid 2, ascorbic acid 0.4. Slices were left to recover for at least 60 min at room temperature prior to recording in a brain slice chamber (Automate Scientific Inc., CA). Slices from the treatment and control groups were positioned on P5002A multi-electrode arrays (Alpha MED Scientific Inc, Japan) and perfused with aCSF at a rate of 2 ml/min, equilibrated with 95% O 2 and 5% CO 2 at 32°C. fEPSPs were invoked through stimulation of the Schaffer collaterals (0.2 msec biphasic pulse) and obtained from the CA1 region of the hippocampus. Threshold for evoking fEPSPs was determined and the stimulus was increased incrementally (5-100 µA) until the maximum amplitude of the fEPSP was reached. All other stimulation paradigms were induced at the same half-maximal stimulus strength, defined as 50% of the stimulus used to produce the maximum fEPSP amplitude, as determined for each individual slice. After a stable baseline recording of 15 minutes was established, LTP was induced using high-frequency stimulation, which consisted of 100 pulses at 100 Hz applied with half-minute intervals. fEPSPs were monitored every 30 seconds for 60 minutes following high-frequency stimulation and were recorded with MED-64 system and Mobius software (Alpha MED Scientific Inc). Potentiation was calculated as the percent increase of the mean fEPSP descending slope following high-frequency stimulation and normalized to the mean fEPSP descending slope of baseline recordings.
Data Analysis
Gene expression data were normalized to the respective control mean values and are expressed as fold changes. Data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey's posthoc test. A p value less than .05 was considered statistically significant. Data are expressed as mean ± SEM.
Results
Effect of a High-Fat Diet on Serum Biomarkers
We compared male Nrf2 +/+ and Nrf2 -/-mice after 5 months of the HFD. Blood glucose levels and serum triglyceride, cholesterol, and inflammatory cytokines levels are shown in Table 1 .
Expression of Antioxidant Enzymes in Nrf2 -/-Mice
Nrf2 deficiency was associated with decreased cerebral mRNA and/ or protein expression of Nrf2/ARE (antioxidant response element)-driven antioxidant enzymes ( Figure 1A and B), whereas expression of antioxidant enzymes, whose promoter does not contain an ARE motif was unaffected ( Figure 1C ). HFD did not result in significant changes in antioxidant gene expression in either group ( Figure 1A-C) .
Increased Oxidative Stress and Senescence in HFD-fed Nrf2 -/-Mice
Although HFD tended to increase protein carbonyl content in the brains of Nrf2 +/+ mice ( Figure 1D ), this difference did not reach statistical significance. HFD-induced oxidative stress was more severe in Nrf2 -/-mice, as shown by the significantly greater level of protein carbonyl content in the brains of HFD-fed Nrf2 -/-mice as compared to that in HFD-fed Nrf2 +/+ mice ( Figure 1D ). HFD-induced oxidative stress was shown to promote cellular senescence in multiple tissues (37, 38) . We found that exacerbation of HFD-induced oxidative stress in Nrf2 -/-mice was associated with upregulation of the senescence marker p16
INK4A (Cdk2na; Figure 1E ) in the brain.
Nrf2 Deficiency Exacerbates Obesity-Induced Neurovascular Uncoupling
In Nrf2 +/+ mice feeding, a HFD resulted in significantly decreased whisker stimulation induced CBF responses in the contralateral whisker barrel cortex, confirming our previous findings (8) (representative laser Doppler CBF tracings are shown in Figure 2A , summary data are shown in Figure 2B ). Neurovascular coupling responses were also decreased in SD-fed Nrf2 -/-mice ( Figure 2 ). We found that Nrf2 deficiency exacerbated the deleterious effects of obesity, quasi-abolishing neurovascular coupling responses (Figure 2A and B) . Nrf2 deficiency and/or HFD feeding could reduce functional hyperemia by impairing neural activity evoked by whisker pad stimulation. To examine this possibility, we assessed the effects of Nrf2 deficiency and/or HFD feeding by recording evoked neural activity. We found that the amplitude of the somatosensory field potentials produced by activation of the whisker pad do not differ between control and Nrf2-deficient mice and are also unaffected by HFD feeding (data not shown). Therefore, interaction of Nrf2 deficiency and obesity is unlikely to contribute to impaired functional hyperemia by modulating the neural activity evoked by whisker stimulation. Changes in mRNA expression of genes relevant for neurovascular dysfunction are shown in Figure 2C .
Nrf2 Deficiency Exacerbates Obesity-Induced BBB Disruption
Using extravasated plasma-derived IgG as a marker for increased hippocampal cerebromicrovascular permeability, we tested the hypothesis that increased obesity-induced oxidative stress in Nrf2 deficiency is associated with an exacerbated BBB disruption. Western blot studies in hippocampal lysates demonstrated very low levels of IgG both in SD-fed and HFD-fed Nrf2 +/+ mice ( Figure 3A and B) . Note: Data are mean ± SEM (n = 4-20 for each data point). *p < .05 vs Nrf2 +/+ (SD), **p < .05 vs. Nrf2 +/+ (HFD), ***p < .05 vs Nrf2 -/-(SD); one-way ANOVA; G-CSF = Granulocyte-colony stimulating factor; HFD = High-fat diet; KC = Keratinocyte-derived chemokine; MIP-2 = Macrophage inflammatory protein 2; RANTES = Regulated on activation, normal T cell expressed and secreted; Wt = Wild type.
There was no significant IgG leakage in SD-fed Nrf2 -/-mice, whereas IgG content in the hippocampus of HFD-fed Nrf2 -/-mice was significantly increased ( Figure 3A and B).
Nrf2 Deficiency Exacerbates Obesity-Induced Neuroinflammation in the Hippocampus
Previous studies suggest that leakage of plasma-derived factors through the damaged BBB has the potential to induce neuroinflammation by activating microglia (7) . We found that in the hippocampi of control mice the number of activated CD68+ microglia was low ( Figure 3C-E) . In the present cohort of Nrf2 +/+ mice HFD feeding did not alter significantly the number of activated microglia in the hippocampi. Nrf2 deficiency per se was also not associated with significant changes in microglia activation. In contrast, in the hippocampi of Nrf2 -/-mice, obesity-induced oxidative stress and BBB disruption was associated with exacerbated neuroinflammation as indicated by the increased number of CD68+ activated microglia ( Figure 3E ). Nrf2 deficiency and obesity did not alter the total number of microglia in the hippocampus ( Figure 3D ). Sustained activation of microglia in the brain of obese Nrf2 deficient mice was associated with an increased expression of several proinflammatory cytokines and chemokines and other microglia activation-related factors ( Figure 3F ) in the hippocampi.
Effects of Nrf2 Deficiency and Obesity on Hippocampal Expression of APP and Genes Involved in APP-Dependent Signaling, Aβ Processing and Tauopathy
As observed in Supplementary Table S2 , neither obesity nor Nrf2 deficiency alone affected cerebral expression of APP, whose proteolysis generates β-amyloid (Aβ), the main component of amyloid plaques. Importantly, HFD-fed Nrf2 -/-mice exhibited significant increases in APP expression. The effects of Nrf2 deficiency and obesity on hippocampal expression of other genes involved in APPdependent signaling, Aβ processing and tauopathy are shown in Supplementary Table 1 . Interestingly, although we did not observe upregulation of either amyloid processing secretases, HFD significantly increased presenilin enhancer 2 levels, which is known to enhance gamma-secretase activity and promote formation of amyloid plaques (39, 40) .
Effects of Nrf2 Deficiency and Obesity on Synaptic Plasticity
Increased oxidative stress and neuroinflammation has been linked to impairment of long-term potentiation, which is thought to promote impairment of memory and learning. In order to characterize the effects of Nrf2 deficiency and obesity on synaptic function, we measured EPSP in the CA1 of hippocampi in response to electrical stimulation of the Schaffer collaterals pathway (with 5 µA steps increased up to 100 µA). Original recordings showing field EPSPs in the CA1 in response to the stimulation of the Schaffer collaterals in each group are shown in Figure 4A . We found that each group of mice exhibited normal basal synaptic properties. In particular, the ratio of evoked responses to the presynaptic fiber volley was similar in the experimental groups, showing that obesity does not affect neuronal EPSP. Following a 100Hz tetanic stimulation, the slope of field EPSP in the CA1 increased significantly less in the SD-fed Nrf2 -/-group as compared to the SD-fed Nrf2 +/+ controls during the 60 minutes experimental period ( Figure 4B ). In the Nrf2 +/+ group, obesity also tended to decrease LTP, however, these differences did not reach statistical significance. In the hippocampi of Nrf2-deficient mice, obesity-induced impairment of LTP was exacerbated ( Figure 4B ).
Nrf2 Deficiency Exacerbates Obesity-Induced Cognitive Impairment
We tested the performance of the mice in the novel object recognition test. We found no significant difference in the time that mice from each group spent exploring the two identical objects placed at the opposite ends of the arena during the acquisition phase, confirming that the location of the objects did not affect the exploration behavior of mice (11, 26) . In the trial phase with two different objects (one novel, the other familiar), control mice explored the novel object for a significantly longer time period, indicating their memory for the familiar object ( Figure 4D ). Among the four groups obese Nrf2 -/-mice exhibited the lowest Recognition Index, which was statistically different from the control values. This result is consistent with their impaired hippocampal-and cortical-dependent recognition memory ( Figure 4D ).
Discussion
This is the first study to demonstrate exacerbation of obesityinduced oxidative stress, neurovascular uncoupling, BBB disruption, and neuroinflammation in a mouse model of genetic Nrf2 deficiency that recapitulates critical aspects of the cerebromicrovascular aging phenotype.
Previous studies provide ample evidence that the Nrf2/ Antioxidant Response Element (ARE) pathway has a critical role in microvascular protection (15) (16) (17) (18) (19) (20) (21) (41) (42) (43) , especially under pathophysiological conditions associated with increased production of ROS. High-fat diet-induced obesity in aged rodents exerts deleterious effects on neurovascular coupling responses, at least in part, due to an increased production of ROS in the microvascular endothelium (8) . Here, we demonstrate that Nrf2 deficiency exacerbates obesity-induced oxidative stress ( Figure 1 ) and neurovascular impairment (Figure 2 ), mimicking the aging phenotype (8) . We predict that significant impairment of a key homeostatic mechanism matching energy supply with the needs of active neuronal tissue likely has a profound negative effect on brain function in elderly obese patients. This prediction is supported by the observations that cognitive function is significantly impaired in obese Nrf2
-/-mice and that pharmacological inhibition of neurovascular coupling responses in control mice is associated with a similar degree of cognitive impairment (11) . Aging in both rodents and primates is associated with Nrf2 dysfunction in the vasculature (20, 21) . Recently, we demonstrated that treatment with a pharmacological activator of Nrf2 (3,5,4′-trihydroxy-trans-stilbene/resveratrol (17)) significantly improves neurovascular coupling responses in aged mice by restoring cerebromicrovascular endothelial function (29) , which associates with cognitive improvement (44) . We have compelling data that resveratrol treatment also rescues endothelial function in both larger arteries and peripheral microvessels in aged high-fat diet-fed mice in a Nrf2-dependent manner (17, 18, 23) . Resveratrol was also shown to exert significant vasoprotective effects in HFDfed primates as well (10, 45) . On the basis of the aforementioned studies, we predict that treatment with Nrf2 activators may rescue cerebromicrovascular function and thereby neurovascular coupling responses in obese subjects as well.
The results of this study show that high-fat diet-induced obesity in Nrf2 deficient mice promotes significant BBB disruption (Figure 3) . The mechanisms of obesity-related BBB disruption are likely multifaceted and may involve increased endothelial oxidative stress (7), which is known to be exacerbated by Nrf2 deficiency (17, 18) . Obesity is known to promote low-grade systemic inflammation, at least in part, by upregulating production of inflammatory cytokines by the adipose tissue (9) . Circulating inflammatory cytokines, derived from adipose tissue, readily reach the cerebral microcirculation impairing the barrier function of cerebromicrovascular endothelial cells. Importantly, Nrf2 activity is known to limit cytokine-induced endothelial effects. Our current study provides evidence that through the damaged BBB in obese Nrf2-deficient mice plasma constituents (e.g., IgG) enter the brain parenchyma (Figure 3) , mimicking the aging phenotype (7) . This observation is important as plasma-derived factors exert multifaceted effects on neuronal function, including the induction of neuroinflammation (13, 46, 47) . There is strong evidence that plasma-derived IgG is a particularly potent stimulus for microglia activation in the brain (7). Other plasma constituents that likely contribute to microglia activation upon BBB disruption include thrombin, fibrinogen, and circulating inflammatory cytokines. Here, we provide evidence that in obese Nrf2-deficient mice, similar to obese aged mice (7), BBB disruption and increased extravasation of plasma constituents are associated with an exacerbated neuroinflammatory response as shown by the increased number of activated microglia and upregulation of inflammatory mediators (e.g., IL-1β (48)) in the hippocampus. On the basis of the present and previous findings we propose that age-related microvascular Nrf2 dysfunction likely contributes to exacerbation of obesity-induced BBB disruption and neuroinflammation in aged mice (7) .
Clinical studies demonstrate that increased inflammation predicts cognitive decline. Results of preclinical studies support this concept by showing that microglia-derived proinflammatory cytokines, chemokines, proteases (MMPs), and reactive oxygen species promote neuronal dysfunction, including impairment of synaptic function. To determine the functional consequences of exacerbated neuroinflammation in obese Nrf2-deficient mice, we studied LTP (an increase in synaptic strength), which plays an important role in the establishment and storage of stable long-term memories in the hippocampus. We found that HFD-induced obesity tended to decrease LTP in the hippocampus, confirming previous findings (49) . In obese Nrf2-deficient mice, LTP was substantially reduced, which, together with neurovascular uncoupling, likely contributes to impaired cognitive performance ( Figure 4A-C) . Interestingly, Nrf2 deficiency itself also appears to decrease LTP, supporting the concept that Nrf2 deficiency exerts multifaceted adverse neuronal effects. For example, recent studies show that Nrf2 ortholog SKN-1 regulates synaptic transmission in C. elegans (50) . Further, in mice, intrahippocampal injections of a lentiviral vector expressing Nrf2 improve spatial learning (51) . The exact mechanisms linking Nrf2 activation to synaptic strength in mice are not understood and should be elucidated in future studies.
Epidemiological studies provide evidence that in addition to the established association of obesity with vascular cognitive impairment, there is a direct relationship between obesity and pathogenesis of AD (reviewed in ref. (52) ). In particular, BBB disruption, increased inflammatory status and oxidative stress are thought to contribute to the pathogenesis of AD, via mechanisms that include dysregulation of AD-related gene expression (7, 26) . To determine whether in Nrf2-deficient mice exacerbated obesity-induced cerebromicrovascular alterations and neuroinflammation were sufficient to trigger early processes involved in the pathogenesis of Alzheimer's disease, we assessed hippocampal expression of genes involved in regulation of the cellular APP-dependent signaling pathways, beta-amyloid generation and processing and the pathogenesis of tauopathy. Importantly, obesity in Nrf2-deficient mice resulted in significant alterations in amyloidogenic gene expression, including upregulation of cerebral expression of APP, whose proteolysis generates Aβ, the main component of amyloid plaques (Supplementary Table S1 ). This finding is consistent with the results of previous studies showing that increased oxidative stress induces APP expression and that Nrf2 deficiency (53) and HFD-induced obesity (54) exacerbate AD pathologies in genetic mouse models.
Collectively, our findings provide evidence that Nrf2-driven free radical detoxification pathways have an important role in neurovascular protection in obesity ( Figure 4D ). We find that Nrf2 dysfunction compromises cerebromicrovascular and brain health, by exacerbating obesity-induced neurovascular uncoupling, BBB disruption, neuroinflammation, and synaptic dysfunction, promoting cognitive impairment. We propose that pathological conditions that impair cellular Nrf2 activity, such as advanced aging (15, (19) (20) (21) 42) , render the cerebral microvasculature vulnerable to the deleterious effects of obesity, which likely plays a critical role in the augmented pathogenesis of VCI and AD. Based on our present and previous The Recognition Index (representing the time spent investigating the novel object relative to the total object investigation) was used as the main index of retention. Data are mean ± SEM. *p < .05 vs Wt (SD). (D) Proposed scheme depicting the likely role of age-related Nrf2 dysfunction in exacerbation of obesity-induced oxidative stress, BBB disruption, neuroinflammation, neurovascular dysfunction, and synaptic dysfunction, all of which contribute to cognitive impairment in obese elderly subjects.
findings, there is a clear opportunity for pharmacological intervention to facilitate induction of Nrf2-driven homeostatic pathways by pharmacological treatments for the prevention of cognitive impairment in obese elderly patients.
